The clinical spectrum of severe childhood malaria in Eastern Uganda.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
03 Sep 2020
Historique:
received: 15 06 2020
accepted: 25 08 2020
entrez: 5 9 2020
pubmed: 5 9 2020
medline: 7 4 2021
Statut: epublish

Résumé

Few recent descriptions of severe childhood malaria have been published from high-transmission regions. In the current study, the clinical epidemiology of severe malaria in Mbale, Eastern Uganda, is described, where the entomological inoculation rate exceeds 100 infective bites per year. A prospective descriptive study was conducted to determine the prevalence, clinical spectrum and outcome of severe Plasmodium falciparum malaria at Mbale Regional Referral Hospital in Eastern Uganda. All children aged 2 months-12 years who presented on Mondays to Fridays between 8.00 am and 5.00 pm from 5th May 2011 until 30th April 2012 were screened for parasitaemia. Clinical and laboratory data were then collected from all P. falciparum positive children with features of WHO-defined severe malaria by use of a standardized proforma. A total of 10 208 children were screened of which 6582 (64%) had a positive blood film. Of these children, 662 (10%) had clinical features of severe malaria and were consented for the current study. Respiratory distress was the most common severity feature (554; 83.7%), while 365/585 (62.4%) had hyperparasitaemia, 177/662 (26.7%) had clinical jaundice, 169 (25.5%) had severe anaemia, 134/660 (20.2%) had hyperlactataemia (lactate ≥ 5 mmol/L), 93 (14.0%) had passed dark red or black urine, 52 (7.9%) had impaired consciousness and 49/662 (7.4%) had hypoxaemia (oxygen saturations < 90%). In-hospital mortality was 63/662 (9.5%) overall but was higher in children with either cerebral malaria (33.3%) or severe anaemia (19.5%). Factors that were independently associated with mortality on multivariate analysis included severe anaemia [odds ratio (OR) 5.36; 2.16-1.32; P = 0.0002], hyperlactataemia (OR 3.66; 1.72-7.80; P = 0.001), hypoxaemia (OR) 3.64 (95% CI 1.39-9.52; P = 0.008), and hepatomegaly (OR 2.29; 1.29-4.06; P = 0.004). No independent association was found between mortality and either coma or hyperparasitaemia. Severe childhood malaria remains common in Eastern Uganda where it continues to be associated with high mortality. An unusually high proportion of children with severe malaria had jaundice or gave a history of having recently passed dark red or black urine, an issue worthy of further investigation.

Sections du résumé

BACKGROUND BACKGROUND
Few recent descriptions of severe childhood malaria have been published from high-transmission regions. In the current study, the clinical epidemiology of severe malaria in Mbale, Eastern Uganda, is described, where the entomological inoculation rate exceeds 100 infective bites per year.
METHODS METHODS
A prospective descriptive study was conducted to determine the prevalence, clinical spectrum and outcome of severe Plasmodium falciparum malaria at Mbale Regional Referral Hospital in Eastern Uganda. All children aged 2 months-12 years who presented on Mondays to Fridays between 8.00 am and 5.00 pm from 5th May 2011 until 30th April 2012 were screened for parasitaemia. Clinical and laboratory data were then collected from all P. falciparum positive children with features of WHO-defined severe malaria by use of a standardized proforma.
RESULTS RESULTS
A total of 10 208 children were screened of which 6582 (64%) had a positive blood film. Of these children, 662 (10%) had clinical features of severe malaria and were consented for the current study. Respiratory distress was the most common severity feature (554; 83.7%), while 365/585 (62.4%) had hyperparasitaemia, 177/662 (26.7%) had clinical jaundice, 169 (25.5%) had severe anaemia, 134/660 (20.2%) had hyperlactataemia (lactate ≥ 5 mmol/L), 93 (14.0%) had passed dark red or black urine, 52 (7.9%) had impaired consciousness and 49/662 (7.4%) had hypoxaemia (oxygen saturations < 90%). In-hospital mortality was 63/662 (9.5%) overall but was higher in children with either cerebral malaria (33.3%) or severe anaemia (19.5%). Factors that were independently associated with mortality on multivariate analysis included severe anaemia [odds ratio (OR) 5.36; 2.16-1.32; P = 0.0002], hyperlactataemia (OR 3.66; 1.72-7.80; P = 0.001), hypoxaemia (OR) 3.64 (95% CI 1.39-9.52; P = 0.008), and hepatomegaly (OR 2.29; 1.29-4.06; P = 0.004). No independent association was found between mortality and either coma or hyperparasitaemia.
CONCLUSIONS CONCLUSIONS
Severe childhood malaria remains common in Eastern Uganda where it continues to be associated with high mortality. An unusually high proportion of children with severe malaria had jaundice or gave a history of having recently passed dark red or black urine, an issue worthy of further investigation.

Identifiants

pubmed: 32883291
doi: 10.1186/s12936-020-03390-7
pii: 10.1186/s12936-020-03390-7
pmc: PMC7470679
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

322

Subventions

Organisme : Wellcome Trust
ID : 091758
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202800
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202800/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 209265
Pays : United Kingdom

Références

Am J Trop Med Hyg. 2013 Apr;88(4):747-756
pubmed: 23358640
Nephrol Ther. 2013 Jun;9(3):160-5
pubmed: 23402997
Arch Pediatr. 2003 Dec;10 Suppl 5:532s-538s
pubmed: 15022777
PLoS One. 2013 Apr 26;8(4):e62214
pubmed: 23638008
Malar J. 2012 Oct 05;11:336
pubmed: 23039275
Afr Health Sci. 2004 Apr;4(1):50-7
pubmed: 15126192
Trans R Soc Trop Med Hyg. 2000 Apr;94 Suppl 1:S1-90
pubmed: 11103309
S Afr Med J. 2013 May;103(5):273
pubmed: 23971102
Trop Med Int Health. 2014 Sep;19 Suppl 1:7-131
pubmed: 25214480
N Engl J Med. 2004 Feb 5;350(6):552-9
pubmed: 14762182
N Engl J Med. 1995 May 25;332(21):1399-404
pubmed: 7723795
Emerg Infect Dis. 2005 Jul;11(7):1118-20
pubmed: 16022794
Malar J. 2014 Mar 21;13:111
pubmed: 24656206
Malar J. 2010 Oct 15;9:285
pubmed: 20946689
Am J Trop Med Hyg. 1996 Nov;55(5):521-4
pubmed: 8940984
Malar J. 2007 Nov 12;6:147
pubmed: 17997848
BMC Med. 2015 Feb 02;13:21
pubmed: 25640706
Malar J. 2013 Jun 15;12:205
pubmed: 23767699
J Pak Med Assoc. 1997 Aug;47(8):213-5
pubmed: 9339620
Acta Trop. 1994 Sep;57(4):289-300
pubmed: 7810385
Trop Med Int Health. 2006 Jan;11(1):115-24
pubmed: 16398762
Clin Infect Dis. 2017 Apr 1;64(7):939-946
pubmed: 28362936
Malar J. 2010 Oct 13;9:282
pubmed: 20939931
Bull Soc Pathol Exot. 2010 Dec;103(5):296-8
pubmed: 20658275
N Engl J Med. 2019 Aug 1;381(5):407-419
pubmed: 31365799
Lancet. 2010 Nov 13;376(9753):1647-57
pubmed: 21062666
BMC Res Notes. 2010 Apr 16;3:104
pubmed: 20398391
Afr J Med Sci. 1971 Apr;2(2):101-8
pubmed: 5111609
Clin Infect Dis. 2012 Apr;54(8):1080-90
pubmed: 22412067
Trans R Soc Trop Med Hyg. 2002 May-Jun;96(3):278-81
pubmed: 12174779
N Engl J Med. 2019 Aug 1;381(5):420-431
pubmed: 31365800
Trans R Soc Trop Med Hyg. 2006 Sep;100(9):817-25
pubmed: 16527319

Auteurs

Peter Olupot-Olupot (P)

Faculty of Health Sciences, Busitema University, Mbale Campus, P.O. Box 1460, Mbale, Uganda. polupotolupot@yahoo.com.
Mbale Clinical Research Institute, P.O. Box 1966, Mbale, Uganda. polupotolupot@yahoo.com.

Charles Engoru (C)

Soroti Regional Referral Hospital, P.O. Box 289, Soroti, Uganda.

Julius Nteziyaremye (J)

Faculty of Health Sciences, Busitema University, Mbale Campus, P.O. Box 1460, Mbale, Uganda.
Mbale Clinical Research Institute, P.O. Box 1966, Mbale, Uganda.

Martin Chebet (M)

Faculty of Health Sciences, Busitema University, Mbale Campus, P.O. Box 1460, Mbale, Uganda.
Mbale Clinical Research Institute, P.O. Box 1966, Mbale, Uganda.

Tonny Ssenyondo (T)

Mbale Clinical Research Institute, P.O. Box 1966, Mbale, Uganda.

Rita Muhindo (R)

Mbale Clinical Research Institute, P.O. Box 1966, Mbale, Uganda.

Gideon Nyutu (G)

KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya.

Alexander W Macharia (AW)

KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya.

Sophie Uyoga (S)

KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya.

Carolyne M Ndila (CM)

KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya.

Charles Karamagi (C)

Makerere University College of Health Sciences, P.O. Box 7072, Kampala, Uganda.

Kathryn Maitland (K)

KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya.
Institute of Global Health Innovation, Imperial College, Medical School Building St Mary's Campus, Imperial College, London, W2 1PG, UK.

Thomas N Williams (TN)

KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya.
Institute of Global Health Innovation, Imperial College, Medical School Building St Mary's Campus, Imperial College, London, W2 1PG, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH